Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid for Hyperactive or Mixed Delirium in ICU
NCT02343575Phase 4Terminated
- Sponsor
- Stanford University
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delirium comparing Valproic Acid with Placebo (2 arms). Primary endpoint: Time to Delirium Resolution up to 5 days. Started Jan 2015; status: terminated.
02
Drugs
valproic acid
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02343575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343575.